Search

Search Constraints

You searched for: Author/Creator Nelson, Joel B.

Search Results

4. Clinical Utility of the Risk Analysis Index as a Prospective Frailty Screening Tool within a Multi-practice, Multi-hospital Integrated Healthcare System. Issue 6 (December 2021)

6. E‐cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayer. Issue 11 (18th June 2019)

8. Proteomic analysis of patient tissue reveals PSA protein in the stroma of benign prostatic hyperplasia. Issue 8 (7th April 2014)

9. The early adoption of intensity‐modulated radiotherapy and stereotactic body radiation treatment among older Medicare beneficiaries with prostate cancer. Issue 15 (16th March 2017)

10. Validation of the Risk Analysis Index for Evaluating Frailty in Ambulatory Patients. Issue 8 (20th April 2020)